hepat
c
viru
hcv
global
public
health
problem
involv
chronic
infect
liver
million
peopl
chronic
hcv
caus
liver
diseas
link
liver
cancer
viral
innat
immun
evas
strategi
human
genet
determin
underli
transit
acut
hcv
infect
viral
persist
support
chronic
infect
host
genet
factor
sequenc
polymorph
gene
host
interferon
system
influenc
outcom
infect
respons
antivir
therapi
recent
insight
hcv
regul
innat
immun
signal
within
liver
reveal
complex
interact
patient
genet
background
viral
host
factor
innat
immun
trigger
control
impart
outcom
hcv
infect
immun
hepat
c
viru
hcv
major
public
health
problem
infect
approxim
million
peopl
worldwid
infect
occur
within
hepatocyt
chief
parenchym
cell
liver
hcv
typic
caus
chronic
infect
major
caus
liver
diseas
liver
transplant
liver
cancer
first
line
immun
defens
hcv
reli
cellintrins
innat
immun
within
hepatocyt
innat
immun
respons
serv
recogn
hcv
nonself
induc
local
antivir
defens
infect
cell
liver
tissu
function
recruit
modul
action
immun
cell
adapt
immun
respons
hepat
innat
immun
therefor
essenti
control
outcom
hcv
infect
immun
howev
major
infect
hcv
fail
mount
product
immun
respons
clear
infect
underscor
problem
hcv
evolv
multipl
mechan
regul
evad
innat
immun
thu
provid
foundat
chronic
infect
standard
care
therapi
hcv
infect
treatment
pegyl
plu
ribavirin
antivir
cytokin
ifn
innat
immun
therapeut
unpleas
patient
infect
difficult
treat
hcv
genotyp
cur
time
firstgener
direct
act
antivir
drug
introduc
clinic
appli
combin
ifn
enhanc
efficaci
reduc
chanc
viral
resist
breakthrough
moreov
underli
hcv
infect
outcom
polymorph
also
refer
human
gene
host
system
innat
antivir
defens
polymorph
influenc
outcom
infect
respons
therapi
understand
hcv
regul
hepat
innat
immun
respons
essenti
guid
improv
hcv
therapi
develop
effect
vaccin
applic
design
new
therapeut
strategi
control
infect
suppress
liver
diseas
perspect
describ
viru
host
control
innat
immun
factor
contribut
hcv
persist
liver
virushost
interact
impact
outcom
infect
immun
current
ifnbas
antivir
therapi
hcv
hepaciviru
member
flavivirida
famili
viral
genom
singl
copi
positivesens
rna
entri
hepatocyt
viru
uncoat
viral
genom
translat
singl
polyprotein
coand
posttransl
process
structur
nonstructur
protein
combin
host
peptidas
two
viralencod
proteas
hcv
nonstructur
protein
assembl
replic
complex
onto
modifi
intracellular
membran
replic
hcv
genom
process
involv
product
antigenom
replic
intermedi
rna
like
accumul
doubl
strand
ds
rna
intermedi
product
new
viral
genom
packag
viral
particl
viral
structur
protein
result
viru
releas
hepatocyt
associ
host
lipoprotein
blood
hcv
present
lipoproteinco
viru
viral
replic
process
hcv
sens
nonself
pathogen
recognit
receptor
prr
host
cell
identifi
bind
pathogen
associ
molecular
pattern
pamp
motif
within
viral
product
lead
coordin
activ
innat
immun
respons
adapt
immun
respons
innat
adapt
arm
immun
includ
crosstalk
liverresid
infiltr
cell
hepatocyt
kupffer
cell
pdc
natur
killer
nk
cell
immun
cell
contribut
host
abil
resolv
hcv
infect
howev
despit
immun
defens
hcv
infect
becom
chronic
acut
infect
outcom
due
combin
host
viral
factor
regul
intracellular
innat
immun
respons
hcv
importantli
inactiv
intracellular
innat
immun
respons
hcv
may
also
result
nonfunct
adapt
immun
respons
inde
prr
signal
specif
mav
requir
function
innat
adapt
respons
infect
west
nile
viru
relat
viru
flavivirida
famili
outsid
scope
perspect
function
adapt
immun
respons
also
critic
resolv
hcv
infect
review
varieti
prr
sens
virus
foreign
invad
within
host
cell
specif
pamp
recognit
activ
innat
immun
signal
rigilik
receptor
rlr
retino
acid
induc
genei
rigi
melanoma
differenti
antigen
cytosol
prr
sens
rna
virus
tolllik
receptor
tlr
mediat
viru
sens
within
endosom
compart
signal
innat
defens
nodlik
receptor
nlr
serv
sens
cytosol
viral
product
viral
metabolit
drive
inflammatori
respons
activ
prr
drive
innat
antivir
proinflammatori
respons
limit
viru
replic
spread
also
serv
recruit
adapt
immun
cell
enhanc
effector
action
site
infect
varieti
nucleic
acid
bind
protein
also
serv
put
prr
engag
viral
nucleic
acid
result
interact
regul
specif
prr
signal
pathway
protein
kinas
r
pkr
exampl
nontradit
prr
dsrna
bind
activ
promot
interact
mitochondri
antivir
signal
protein
mav
impart
prr
signal
innat
immun
shown
hcv
recogn
rigi
within
hour
infect
activ
downstream
signal
prior
extens
viral
protein
synthesi
rigi
signal
hcv
infect
initi
upon
bind
pamp
rna
includ
expos
triphosph
nontransl
region
hcv
genom
rna
rich
poli
uuc
ribonucleotid
multicompon
pamp
motif
present
nonself
rna
signatur
detect
rigi
activ
innat
immun
triphosph
poli
uuc
region
opposit
end
viral
genom
known
intragenom
interact
end
rna
bring
proxim
rigi
bind
activ
hcv
replic
intermedi
hcv
pamp
could
present
rigi
either
incom
genom
viral
uncoat
hcv
genom
amplif
hcv
rna
bind
induc
rigi
conform
chang
promot
oligomer
transloc
cytosol
intracellular
membran
process
requir
interact
chaperon
protein
ubiquitin
ligas
togeth
rigi
compris
translocon
facilit
interact
rigi
signal
adaptor
protein
mav
rigimav
interact
promot
format
mav
signalosom
propag
activ
downstream
effector
molecul
includ
transcript
factor
varieti
proinflammatori
cytokin
fig
also
implic
prr
sens
hcv
although
role
hcv
detect
immun
still
fulli
understood
endosom
sensor
dsrna
express
number
cell
type
within
liver
includ
hepatocyt
liver
resid
macrophag
kupffer
cell
signal
transmit
adaptor
protein
trif
activ
product
type
ifn
proinflammatori
cytokin
chemokin
well
apoptot
signal
fig
wherea
synthet
dsrna
ligand
induc
depend
signal
cell
express
ectop
within
hour
hcv
infect
cell
activ
signal
includ
cytokin
product
later
time
day
infect
ligand
hcv
recent
identifi
hcv
dsrna
replic
intermedi
accumul
late
hcv
replic
interact
dsrna
bind
domain
unlik
incom
viral
genom
earli
replic
product
serv
ligand
cytokin
product
requir
sever
day
induc
instead
hcv
ligand
probabl
present
either
follow
uptak
extracellular
hcv
dsrna
either
die
cell
extracellular
milieu
scaveng
receptor
nearbi
uninfect
cell
accumul
dsrna
viral
replic
intermedi
expos
either
endosom
autophag
vesicl
therefor
hcv
infect
signal
could
serv
secondari
innat
immun
detect
surveil
system
uninfect
cell
initi
rigi
detect
hcv
possibl
involv
set
antivir
state
within
region
liver
chemokin
induct
recruit
cell
liver
hcv
infect
interestingli
cytokin
induct
profil
follow
activ
hcv
distinct
induc
dsrna
mimic
polyinosinecytosin
suggest
level
specif
attribut
interact
possibl
induct
antivir
proinflammatori
respons
rigi
could
contribut
hcvmediat
pathogenesi
includ
liver
inflamm
fibrosi
progress
chronic
infect
although
mechan
immunopathogenesi
unknown
addit
role
rigi
signal
mediat
hcv
liver
diseas
vivo
known
recent
studi
reclassifi
wellknown
hcv
antivir
protein
kinas
pkr
genuin
prr
hcv
activ
contribut
innat
immun
signal
ifn
product
pkr
dsrna
bind
protein
whose
kinas
activ
induc
bind
hcv
dsrna
phosphoryl
alpha
subunit
eukaryot
initi
factor
suppress
host
mrna
translat
hcv
translat
hcv
use
intern
ribosom
entri
site
ire
translat
mechan
insensit
level
phosphoryl
suppress
capdepend
translat
host
mrna
known
pkr
bind
hcv
dsrna
also
activ
kinaseindepend
signal
transduct
cascad
drive
induct
specif
isg
product
signal
mav
irf
prior
rigi
activ
fig
hcv
ligand
pkr
structur
rna
ire
hcv
rna
mechan
govern
pkr
rigi
signal
crosstalk
still
defin
studi
reveal
role
pkr
prr
cooper
rigi
drive
downstream
gene
express
mediat
antivir
defens
antivir
defens
trigger
pathogen
recognit
signal
induc
ifn
drive
express
hundr
isg
encod
innat
immun
effector
impart
control
viru
replic
spread
recent
studi
directli
compar
antivir
activ
nearli
isg
reveal
group
isg
specif
isg
bioset
exhibit
coordin
synergist
virusspecif
antivir
function
hcv
bioset
includ
irf
famili
member
signal
transduct
factor
specif
isg
potent
viral
regulatori
activ
mani
still
undefin
mechan
action
tabl
direct
antivir
isg
action
import
control
hcv
replic
full
restrict
hcv
infect
mediat
addit
action
innat
immun
signal
amplif
irf
virusrespons
pathway
primari
acut
hcv
infect
clear
spontan
high
initi
viremia
suggest
high
level
rapid
prr
signal
innat
immun
induct
follow
sens
hcv
pamp
control
acut
hcv
infect
howev
despit
effect
nonself
detect
hcv
rigi
pkr
trigger
innat
immun
program
mani
peopl
acut
hcv
infect
effect
control
viru
develop
chronic
infect
high
frequenc
chronic
infect
reflect
fact
hcv
evolv
sever
mechan
evad
suppress
innat
immun
result
hcv
progress
chronic
review
viral
proteas
central
compon
hcv
innat
immun
evas
strategi
multifunct
proteas
requir
hcv
replic
process
hcv
polyprotein
sever
site
liber
viral
ns
protein
proteas
complex
anchor
intracellular
membran
transmembran
domain
amphipath
amino
terminu
facilit
membran
associ
cleavag
membraneanchor
substrat
block
rigi
signal
addit
proteolyt
process
hcv
polyprotein
target
cleav
mav
intracellular
membran
prevent
signal
transduct
fig
mav
must
anchor
membran
downstream
signal
cleavag
event
prevent
activ
rigi
pathway
acut
infect
abrog
ifn
induct
support
progress
chronic
infect
howev
note
hepatotrop
virus
includ
hepat
viru
hav
gb
viru
b
gvbb
encod
proteas
also
cleav
mav
gvbb
mediat
chronic
infect
marmoset
hav
gener
becom
chronic
thu
mav
cleavag
probabl
necessari
suffici
viral
chronic
cleavag
mav
previous
thought
occur
mitochondri
outer
membran
primari
site
mav
local
howev
know
mav
transmembran
domain
also
anchor
protein
divers
site
within
intracellular
membran
network
peroxisom
mitochondrialassoci
membran
mam
er
membran
subdomain
resid
junction
er
mitochondria
proteas
complex
local
membran
hcv
infect
howev
rather
cleav
mav
outer
mitochondri
membran
target
cleav
mamloc
mav
process
abrog
rigi
signal
despit
level
intact
mav
remain
mitochondria
therefor
hcv
infect
mamresid
mav
like
transduc
rigi
pathway
signal
cleavag
mav
hcv
infect
also
shown
vivo
liver
patient
chronic
hcv
infect
importantli
patient
cleav
mav
exhibit
lower
level
ifn
pathway
activ
thu
mav
cleavag
hcv
proteas
disrupt
rigi
signal
innat
antivir
immun
attenu
ifn
product
hcv
proteas
also
proteolyt
target
trif
signalingadaptor
protein
cell
cultur
studi
shown
trif
cleav
vitro
specif
trif
proteolyt
fragment
detect
hcv
infect
rel
abund
trif
protein
decreas
like
due
destabil
degrad
follow
cleavag
cleavag
trif
suggest
control
signal
must
import
success
hcv
infect
perhap
prevent
excess
inflamm
could
impart
viral
suppress
block
chemokin
induct
requir
vigor
cytotox
cell
ctl
respons
known
import
hcv
clearanc
rna
sens
mechan
signal
trif
impart
innat
immun
inflammatori
respons
also
describ
target
trif
may
also
contribut
hcv
persist
block
action
infect
hcv
regul
pkr
activ
viral
infect
howev
regul
complex
need
redefin
context
pkr
seemingli
oppos
proand
antihcv
role
infect
pkrmediat
translat
suppress
host
mrna
hcv
infect
ifn
therapi
inhibit
translat
host
factor
import
hcv
replic
cellular
growth
pkr
function
antivir
molecul
also
inhibit
translat
isg
ifn
pkr
function
provir
molecul
furthermor
pkrkinas
independ
signal
hcv
infect
activ
specif
isg
would
consid
antivir
know
hcv
sever
pkrinactiv
strategi
level
pkrprr
signal
direct
action
pkr
cleavag
mav
level
pkrregul
translat
inhibit
like
contribut
viral
persist
andor
ifn
therapi
respons
exact
mechan
time
would
support
viral
persist
still
unclear
fig
possibl
inactiv
pkrtranslat
suppress
could
function
specif
time
infect
exampl
suppress
mavsdepend
signal
ensur
requisit
synthesi
host
factor
requir
maintain
cellular
growth
support
environ
persist
hcv
replic
ifnbas
therapi
standard
cours
therapi
hcv
ifn
antivir
cytokin
induc
express
hundr
isg
mani
antivir
immunomodulatori
activ
limit
viru
replic
spread
well
prime
adapt
immun
respons
hcv
infect
fact
acutelyinfect
patient
ifntherapi
extrem
success
prevent
chronic
infect
howev
chronic
infect
patient
respons
ifnbas
therapi
variabl
mani
patient
maintain
high
level
hcv
viremia
spite
ifn
treatment
propos
low
effect
ifn
therapi
chronic
infect
hcv
attribut
combin
viral
host
factor
contribut
regul
ifn
action
treatmentinduc
clearanc
fig
viral
factor
highli
predict
ifn
treatment
respons
viral
genotyp
major
hcv
genotyp
defin
sequenc
conserv
variat
divid
subtyp
viral
quasispeci
interestingli
patient
infect
differ
hcv
genotyp
differenti
therapi
respons
patient
infect
hcv
genotyp
exhibit
highest
respons
rate
therapi
patient
achiev
sustain
virolog
respons
svr
patient
hcv
genotyp
infect
achiev
svr
summar
inde
hcv
genotyp
induc
high
level
hepat
isg
express
infect
patient
liver
therapi
result
ifninsensit
phenotyp
attenu
treatment
respons
explain
viral
genotyp
differ
therapi
respons
hcv
persist
liver
spite
high
level
ifn
signal
elev
hepat
isg
mani
known
antivir
action
within
hcvinfect
hepatocyt
hcv
protein
includ
core
could
antagon
ifn
signal
jakstat
pathway
inactiv
review
suppress
specif
isg
could
otherwis
limit
hcv
infect
fig
addit
known
genotyp
differ
hcvmediat
immun
regul
like
contribut
observ
differ
therapi
respons
exampl
differ
genotyp
differenti
bind
regul
pkr
ifnresist
viral
genotyp
better
abl
block
pkr
function
importantli
viral
sequenc
encod
pephdpkr
inhibitori
domain
pkr
bind
domain
show
evolut
hcv
genotyp
support
idea
potenti
determin
genotypespecif
clinic
outcom
addit
differenti
level
mav
cleavag
among
hcv
genotyp
found
liver
hcv
patient
fulli
cleav
mav
genotyp
exhibit
lower
level
pretherapi
isg
express
interestingli
higher
pretherapi
genet
variabl
hcv
within
major
genotyp
especi
within
sequenc
core
correl
success
therapi
outcom
taken
togeth
data
suggest
alter
sequenc
viral
regulatori
factor
lead
increas
immun
regul
hcv
infect
increas
immun
regul
benefici
viru
would
predict
prevent
pretherapi
induct
isg
therebi
make
viru
suscept
hcv
therapi
ifn
therapi
induc
mani
antihcv
isg
see
tabl
unlik
singl
isg
regul
hcv
complet
govern
outcom
ifn
therapi
hcv
infect
within
liver
singl
isg
among
express
prior
therapi
associ
poor
respons
treatment
rather
overal
composit
induc
isg
associ
poor
therapi
respons
inde
like
combin
factor
mediat
control
innat
immun
ifn
signal
along
viral
host
genet
variabl
discuss
contribut
differenti
respons
ifnbas
therapi
hcv
patient
viral
genotyp
differ
influenc
clinic
outcom
ifnbas
therapi
host
genet
differ
also
play
role
outcom
genomewid
associ
studi
gwa
identifi
singlenucleotid
polymorph
snp
upstream
locu
predict
success
clinic
outcom
hcv
therapi
spontan
hcv
clearanc
snp
associ
alter
mrna
express
encod
antivir
cytokin
suggest
express
level
like
associ
hcv
clearanc
respons
therapi
note
sever
earli
studi
fail
find
alter
mrna
express
associ
snp
specif
realtim
pcr
primer
differenti
close
relat
increas
clear
identifi
snp
locu
impact
express
within
liver
peripher
blood
mononuclear
cell
whole
blood
minorunfavor
allelehaplotyp
result
less
express
detail
analys
snp
within
haplotypegenom
block
gene
locu
reveal
candid
function
snp
involv
hcv
natur
treatmentbas
clearanc
fig
howev
studi
function
genet
element
yet
defin
singl
causal
variant
variat
regul
mrna
express
locat
current
candid
casual
snp
within
gene
suggest
possibl
regulatori
mechan
see
fig
snp
appear
impact
express
unlik
snp
simpli
linkag
disequilibrium
gene
involv
hcv
pathogenesi
defin
polymorph
enhanc
hcv
therapi
respons
rate
import
develop
new
therapeut
strategi
suppress
hcv
treatment
recombin
better
understand
role
host
respons
hcv
infect
recent
studi
show
patient
unfavor
genotyp
depress
innat
immun
function
particularli
respect
nk
cell
suggest
decreas
express
affect
immun
therefor
clearanc
hcv
addit
dinucleotid
polymorph
creat
disrupt
open
read
frame
new
gene
identifi
fig
case
propos
loss
express
protect
hcv
base
current
data
still
clear
role
differenti
respons
hcv
therapi
clear
locu
import
immun
control
hcv
infect
type
iii
ifn
includ
close
relat
cytokin
well
share
homolog
gene
function
slightli
differ
manner
limit
discuss
cytokin
antivir
immunomodulatori
activ
similar
type
ifn
signal
receptor
consist
subunit
converg
jakstat
pathway
induc
similar
isg
profil
type
ifn
inhibit
hcv
replic
vitro
review
howev
cellular
produc
receptor
protein
type
iii
ifn
limit
distribut
type
ifn
suggest
local
role
type
iii
ifn
immun
interestingli
kinet
isg
induct
vari
cytokin
induc
sustain
express
isg
unlik
signal
becom
refractori
repeat
applic
function
cooper
type
ifn
impart
enhanc
isg
induct
antivir
activ
therefor
could
specul
innat
immun
respons
hcv
provid
local
sustain
activ
isg
specif
cell
type
infect
liver
prime
effect
immun
respons
innat
adapt
level
hcv
clearanc
fact
emerg
new
candid
hcv
therapi
lower
side
effect
treatment
like
due
restrict
receptor
distribut
still
clear
genet
polymorph
associ
natur
therapyinduc
control
hcv
found
specif
within
loci
specif
would
play
key
role
host
respons
hcv
studi
aim
understand
similar
gene
activ
regul
hcv
infect
well
determin
cell
type
product
mechan
induct
cytokin
hcv
infect
need
particular
new
studi
need
continu
care
discrimin
virtual
indistinguish
gene
protein
mrna
level
moreov
need
actual
demonstr
express
protein
mrna
level
regul
patient
well
understand
relationship
impact
level
foundat
understand
role
cytokin
hcv
immun
control
respons
therapi
liver
polymorph
associ
respons
treatment
wholli
predict
hcv
therapi
infect
outcom
patient
favor
genotyp
respond
current
ifnbas
therapi
therefor
factor
must
contribut
success
outcom
therapi
fact
strongest
predictor
respons
therapi
dictat
pretreat
express
pattern
isg
mrna
within
liver
patient
pretherapi
induct
isg
mrna
hepatocyt
achiev
lowest
therapi
respons
rate
know
correl
lower
therapi
respons
rate
possibl
pretherapi
induct
isg
prevent
induct
isg
level
therapi
due
activ
neg
regul
lead
refractori
signal
pkr
translat
suppress
isg
prevent
effector
function
preclud
effect
therapi
respons
see
fig
interestingli
kupffer
cell
resid
liver
macrophag
pretherapi
induct
level
isg
also
strong
predictor
therapi
respons
kupffer
cell
phenotyp
opposit
seen
hepatocyt
virtual
nonrespond
lack
pretherapi
induct
isg
respond
stronglyinduc
isg
suggest
hcv
infect
kupffer
cell
activ
induc
isg
either
cytokin
signal
phagocytosi
sens
viral
product
fig
may
play
key
protect
role
host
therapi
respons
hcv
clearanc
understand
macrophag
activ
interact
hepatocyt
immun
control
hcv
infect
treatment
play
key
role
determin
mechan
drive
phenotyp
well
hcv
pathogenesi
patient
pretherapi
induct
isg
hepatocyt
other
known
host
genet
differ
well
hcvinduc
isg
express
profil
liver
cell
subtyp
predict
therapi
respons
howev
often
independ
predictor
therapi
respons
mean
patient
genotyp
definit
predict
hepat
isg
activ
state
thu
isg
express
profil
hepatocyt
macrophag
still
singl
best
predictor
therapi
respons
virtual
patient
lack
preinduc
hepat
isg
respond
therapi
lack
preinduc
macrophag
isg
fail
therapi
therefor
host
genotyp
host
loci
viral
genotyp
like
predispos
hcv
infect
patient
particular
therapi
respons
outcom
combin
factor
includ
crosstalk
liver
cell
subtyp
environment
factor
age
race
sex
ultim
dictat
respons
therapi
fig
hepat
pretherapi
isg
mrna
express
profil
patient
chronic
hcv
infect
indic
ifn
either
type
type
iii
produc
endogen
infect
cell
type
type
type
iii
ifn
product
could
infect
cell
well
bystand
cell
respond
viru
exposur
importantli
fact
patient
favor
snp
gener
higher
level
lower
pretherapi
hepat
isg
level
higher
macrophag
isg
level
suggest
cell
type
within
liver
besid
infect
hepatocyt
could
produc
ifn
product
type
andor
type
iii
ifn
respons
ifn
level
receptor
downstream
signal
infect
hepatocyt
like
regul
hcv
infect
know
case
type
ifn
quit
possibl
also
true
see
fig
propos
number
virushost
interact
context
liver
could
drive
hepat
product
ifn
proinflammatori
cytokin
fig
viral
protein
accumul
infect
hcv
activ
rigi
andor
pkr
action
hepatocyt
stimul
activ
lead
earli
albeit
transient
induct
isg
express
hcv
also
induc
type
iii
ifn
primari
liver
cultur
resid
infiltr
liver
myeloid
cell
includ
plasmacytoid
dendrit
cell
pdc
kupffer
cell
could
produc
type
iii
ifn
stimul
viral
product
neighbor
infect
hepatocyt
particular
exosom
transfer
hcv
rna
hepatocyt
neighbor
pdc
stimul
high
level
type
type
iii
ifn
product
well
rigi
signal
kupffer
cell
may
abl
phagocytos
hcv
stimul
local
type
iii
ifn
product
local
product
ifn
could
serv
obviou
antivir
function
suppress
acut
hcv
infect
chronic
product
ifn
particularli
also
regul
isg
express
antivir
function
limit
efficaci
local
hepat
ifn
ifn
therapi
hcv
infect
cytokin
produc
pdc
kupffer
cell
infect
hepatocyt
within
liver
could
also
impact
recruit
immun
cell
liver
includ
myeloid
cell
nk
cell
cell
hcv
regul
cytokin
induct
could
play
key
regulatori
role
dictat
activ
immun
cell
effect
adapt
immun
respons
hcv
result
chang
hcvinduc
pathogenesi
vari
outcom
ifn
therapi
cross
talk
liver
cell
subtyp
would
expect
influenc
patient
genotyp
favor
genotyp
increas
immun
cell
function
better
viral
clearanc
suggest
understand
cross
talk
liver
cell
subtyp
key
defin
complex
natur
type
type
iii
ifn
action
prime
adapt
immun
respons
especi
gener
virusspecif
ctl
therapi
outcom
hcv
suppress
immun
respons
clear
hcv
viru
exposur
often
carri
forward
chronic
infect
chronic
hcv
link
dysregul
innat
adapt
immun
signal
viralinduc
cytotoxicityapoptosi
hepat
environ
togeth
affect
infect
outcom
respons
therapi
like
contribut
liver
fibrosi
cirrhosi
hcv
accomplish
immun
dysregul
evad
host
innat
immun
respons
multipl
point
prevent
initi
coordin
innat
immun
prime
entir
immun
respons
includ
adapt
immun
lead
increas
viral
replic
contribut
viral
persist
within
liver
microenviron
multipl
cell
type
contribut
immun
respons
toward
hcv
interrupt
aspect
innat
respons
hcv
could
lead
unbalanc
ineffect
immun
respons
natur
treatmentinduc
hcv
clearanc
could
drive
progress
liver
diseas
full
understand
viral
immun
modul
impart
infect
outcom
requir
us
defin
spectrum
antivir
immunomodulatori
cytokin
govern
crosstalk
variou
cell
type
within
complex
liver
tissu
exampl
respons
crosstalk
one
anoth
hepat
respons
proinflammatori
cytokin
other
implic
hepat
inflamm
key
produc
cell
cytokin
infect
liver
product
cytokin
stimul
andor
regul
hcv
infect
may
also
role
hepat
stellat
cell
mediat
process
recent
implic
drive
inflammatori
respons
hcvinfect
hepatocyt
clinic
trial
alreadi
show
great
promis
role
effect
treatment
antivir
cytokin
fewer
side
effect
observ
patient
undergo
therapi
genet
studi
reveal
insight
polymorph
linkag
effect
immun
respons
clear
hcv
note
genotyp
one
factor
predict
therapi
respons
fig
knowledg
one
genotyp
could
use
guid
therapi
decis
genet
studi
defin
addit
host
factor
impact
hcv
clearanc
andor
diseas
progress
help
us
understand
dictat
success
immun
respons
treatment
outcom
hcv
quit
like
upcom
treatment
era
hcv
may
fulli
embrac
direct
act
antivir
alon
proteas
replic
complex
polymeras
inhibitor
absenc
ifn
combin
therapi
therapi
provid
major
step
forward
treat
hcv
infect
patient
viral
breakthrough
drug
resist
need
consid
monitor
care
situat
addit
efficaci
drug
hcv
genotyp
genotyp
still
need
determin
research
continu
onward
excit
discoveri
develop
doubt
reveal
key
factor
requir
success
immun
hcv
come
age
person
medicin
knowledg
could
lead
individu
tailor
hcv
therapi
base
knowledg
one
host
viral
genotyp
understand
detail
compon
effect
immun
respons
hcv
innat
adapt
level
use
guid
develop
long
desir
hcv
vaccin
innat
sens
hcv
infect
hepatocyt
occur
combin
action
pkr
rigi
protein
recogn
specif
featur
hcv
includ
dsrna
hcv
ire
hcv
poli
uuc
pamp
earli
infect
dsrna
accumul
follow
hcv
infect
viru
particl
coat
apolipoprotein
lp
depict
uptak
hcv
dsrna
die
cell
later
infect
recognit
lead
downstream
signal
indic
arrow
result
induct
antiviralimmunomodulatori
gene
proinflammatori
cytokin
see
text
mechanist
detail
dash
box
mark
locat
mitochondrialassoci
er
membran
mam
site
mav
signal
mechan
lead
hepat
activ
hcv
infect
yet
fulli
character
immun
evas
hcv
hepatocyt
occur
sever
point
viral
infect
propos
regul
shown
hcv
proteas
cleav
signal
adaptor
mav
mitochondrialassoci
er
membran
mam
region
indic
dash
box
trif
inactiv
pkr
rigi
signal
pathway
prevent
induct
immunomodulatori
innat
antivir
gene
allow
hcv
replic
hcv
infect
control
induct
yet
defin
hcv
protein
inactiv
pkr
kinasedepend
activ
host
translat
factor
reactiv
protein
translat
infect
hcvinfect
hepatocyt
number
possibl
factor
influenc
therapi
respons
pegyl
factor
includ
patient
genotyp
viral
genotyp
activ
statu
hepat
isg
prior
therapi
includ
isg
neg
regul
ifnar
make
cell
refractori
ifn
signal
hcv
could
regul
host
respons
infect
cell
prevent
ifn
therapi
action
directli
indirectli
block
jakstat
signal
isg
protein
effector
function
capdepend
protein
translat
cytokin
requir
function
adapt
immun
respons
see
purpl
box
b
tabl
key
factor
determin
hcv
therapi
respons
svr
sustain
virolog
releas
b
nucleotid
snp
schemat
gene
locu
chromosom
depict
base
determin
sequenc
end
mrna
signific
proxim
snp
around
associ
respons
ifn
therapi
shown
map
indic
red
dash
candid
function
snp
near
locu
along
possibl
regulatori
mechan
site
depict
sever
snp
test
candid
function
snp
role
splice
role
protein
bioactiv
found
affect
liver
contain
differ
cell
type
secret
ifn
upon
stimul
hcv
infect
includ
hepatocyt
infiltr
plasmacytoid
dendrit
cell
pdc
kupffer
cell
activ
cell
requir
prime
adapt
immun
respons
hcv
play
major
role
eventu
viral
clearanc
type
type
iii
ifn
act
uninfect
hepatocyt
induc
antivir
state
limit
viru
spread
infect
cell
hcv
evad
ifn
induct
viralmedi
process
includ
cleavag
mav
trif
impact
hcv
outcom
infect
diseas
progress
crosstalk
hepatocyt
hepat
stellat
cell
hcv
infect
also
shown
induc
inflammatori
cytokin
chemokin
depict
